德克索鲁比或埃皮鲁比与脂质体德克索鲁比治疗-心脏毒性的差异
Barbara Buchalska1, Katarzyna Kamińska2, Michał Kowara1
1Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.
Cardiovascular toxicology
|January 14, 2025
概括
脂质体内多克索鲁比 (L-DOX) 为传统多克索鲁比 (DOX) 化疗提供了一个有前途的替代方案. 在治疗恶性瘤方面,L-DOX显著降低了心脏毒性,同时保持了可比的疗效.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多克索鲁比 (DOX) 是各种癌症的重要化疗剂.
- DOX诱导的心脏毒性 (DIC) 是一个主要的剂量限制副作用.
- DIC的危险因素包括累积的DOX剂量,并发症和其他心脏毒剂.
研究的目的:
- 评估脂质体多克索鲁比辛 (L-DOX) 作为减轻DOX诱导心脏毒性的策略.
- 为了比较L-DOX与常规DOX的心脏毒性概况和疗效.
主要方法:
- 对比L-DOX和传统DOX的元分析,临床和临床前研究的综述.
- 评估心脏功能标志物,包括左心室喷射率 (LVEF).
主要成果:
- 与传统的DOX相比,L-DOX治疗与LVEF和其他心脏功能的减少有关.
- 在治疗恶性瘤方面,L-DOX的疗效与传统的DOX相美.
- L-DOX包括基化 (PLD) 和非基化 (NLPD) 配方.
结论:
- 多克索鲁比的脂质体配方代表了癌症治疗的重大进步.
- 对于需要多克索鲁比辛治疗的患者来说,L-DOX提供了更安全的替代方案,最大限度地降低了心脏风险.
- 对L-DOX的进一步研究可能会导致改进的癌症治疗方案,从而改善患者的治疗结果.
相关概念视频
Heart Failure Drugs: Inotropic Agents
511
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
511
Tissue-Drug Binding: Localization of Drugs and its Significance
61
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
61
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


